Skip to main content

Gout

Abstract

Gout is a crystal deposition disease caused by raised levels of uric acid in the blood (hyperuricaemia) with persistence of hyperuricemia at levels higher than a serum saturation of 6.8 mg/dl leads to formation of monosodium urate (MSU) crystals and their deposition in joints and other tissues. However, only a minority of individuals with elevated serum uric acid (sUA) levels ever develop gout, emphasizing the importance of other factors in determining crystal formation including Genetics, Gender, age, Diet and alcohol intake, Obesity, some medications and medical conditions a correct diagnosis of gout is essential for the appropriate management, in 2011 the European League Against Rheumatism (EULAR) published an updated evidence based recommendations for diagnosis of gout. Although gout is well understood condition and good therapeutic options are available, it tends to be poorly managed, so The 2012 The American College of Rheumatology (ACR) guidelines for Management of Gout were designed to emphasize safety and quality of therapy and to reflect best practice. New approaches to urate lowering have led to mechanism-based therapies such as: non-purine, selective inhibitor of xanthine oxidase, URAT-1 inhibitors and a recombinant chimeric mammalian uricase. Three IL-1β antagonists — anakinra, rilonacept and canakinumab are being evaluated as an emerging therapies for gout.

References

  1. M Doherty. New insights into the epidemiology of gout. Rheumatology 2009; 48: ii2–ii8.

    Article  Google Scholar 

  2. Conway N, Schwartez S. Diagnosis and management of acute gout. Med Health R I 2009; 92: 356–358.

    PubMed  Google Scholar 

  3. Mc Gill NW, Dieppe PA. The role of serum and synovial fluid components in the promotion of urate crystal formation. J Rheumatol 1991; 18: 1042–1045.

    CAS  Google Scholar 

  4. Lin KC, Lin HY, Chon P. The interaction between uric acid level and other risk factors in the development of gout among asymptomatic hyperuricemicmen in a prospective study. J Rheumatol 2000; 27: 1501–1505.

    CAS  PubMed  Google Scholar 

  5. Graessler J, Graessler A, Unger S, et al. Association of the human uratetransporter 1 with reduced renal uric acid excretion and hyperuricemia in a German Caucasian population. Arthritis Rheum 2006; 54: 292–300.

    CAS  Article  Google Scholar 

  6. Le MT, Shatiu M, Mu W, Johnson RJ. SLC2A9 – a fructose transporter identified as a novel uric acid transporter. Nephrol Dial Transplant 2008; 23: 2746–2749.

    CAS  Article  Google Scholar 

  7. Wallace K, Riedel A, Joseph-Ridge N, Wortmann R. Increasing prevalence of gout and hyperuricemia over 10 years among older adults in a managed care population. J Rheumatol 2004; 31: 1582–1587.

    PubMed  Google Scholar 

  8. Choi H, Atkinson K, Karlson E, Willett W, Curhan G. Purine-rich foods, dairy and protein intake, and the risk of gout in men. N Engl J Med 2004; 350: 1093–1103.

    CAS  Article  Google Scholar 

  9. Choi H, Atkinson K, Karlson E, Willett W, Curhan G. Alcohol intake and risk of incident gout in men: a prospective study. Lancet 2004; 363: 1277–1281.

    Article  Google Scholar 

  10. Choi HK, Curhan G. Soft drinks, fructose consumption, and the risk of gout in men: prospective cohort study. Br Med J 2008; 336: 309–312.

    Article  Google Scholar 

  11. Choi HK, Atkinson K, Karlson EW, et al. Obesity, weight change, hypertension, diuretic use, and risk of gout in men: the health professionals follow up study. Arch Intern Med 2005; 165: 742–748.

    Google Scholar 

  12. KG Saag, H Choi. Epidemiology, risk factors, and lifestyle modifications for gout. Arthritis Res Ther 2006; 8: S2.

    Article  Google Scholar 

  13. Richette P, Bardin T. Gout. Lancet 2010; 375: 318–328.

    CAS  Article  Google Scholar 

  14. N Schlesinger. Diagnosis of gout: clinical, laboratory, and radiologic findings. Am J Manag Care 2005; 11 : S443–S450.

    PubMed  Google Scholar 

  15. Dirken-Heuensfeldt KJ, Teunissen TA, Van de lisdonk EH, et al. Clinical features of women with gout arthritis: a systematic review. Clin Rheumatol 2010;29: 575–583.

    Article  Google Scholar 

  16. Hamburger M, Baraf HS, Adamson TC III, Basile J, et al. 2011 recommendations for the diagnosis and management of gout and hyperuricemia. Phys Sports Med 2011; 39: 98–123.

    Article  Google Scholar 

  17. Khanna D, FitzGerald JD, Khanna PP, Bae S, Singh MK, Neogi N, et al. 2012 American College of Rheumatology guidelines for management of gou. Part 1: systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia. Arthritis Care Res (Hoboken) 2012; 64: 1431–1446.

    CAS  Google Scholar 

  18. Khanna D, Khanna PP, FitzGerald JD, Singh MK, Bae S, Neogi T, et al. 2012 American College of Rheumatology guidelines for management of gou. Part 2: Therapy and anti-inflammatory prophylaxis of acute gouty arthritis. Arthritis Care Res (Hoboken) 2012; 64: 1447–1461.

    CAS  Google Scholar 

  19. Crittenden DB, Pillinger MH. New therapies for gout. Annu Rev Med 2013; 64: 325–337.

    CAS  Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Hanan Abdel Rehim MD.

Rights and permissions

This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Rehim, H.A. Gout. Egypt J Intern Med 26, 35–39 (2014). https://doi.org/10.4103/1110-7782.139514

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.4103/1110-7782.139514

Keywords

  • Gout
  • hyperuricemia
  • recommendations for diagnosis and management